Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells-Reference-Cited by-同舟云学术

Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells

Published:2016-08-01 Issue:5 Volume:197 Page:1597-1608
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Galaine Jeanne,Kellermann Guillaume,Guillaume Yves,Boidot Romain^ORCID,Picard Emilie,Loyon Romain^ORCID,Queiroz Lise,Boullerot Laura,Beziaud Laurent,Jary Marine^ORCID,Mansi Laura^ORCID,André Claire,Lethier Lydie,Ségal-Bendirdjian Evelyne^ORCID,Borg Christophe,Godet Yann,Adotévi Olivier

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Multiple roles for CD4+T cells in anti-tumor immune responses

2. CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful

3. The immune contexture in human tumours: impact on clinical outcome

4. Peptide epitope identification for tumor-reactive CD4 T cells

5. Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumor immunostimulatory activity of the traditional Chinese medicine polysaccharide on hepatocellular carcinoma;Frontiers in Immunology;2024-02-22

2. SLC25 family with energy metabolism and immunity in malignant tumors;Oncologie;2023-12-06

3. A novel observation: effect of anionic gelatin nanoparticle on stromal cells;Journal of Biomaterials Science, Polymer Edition;2023-10-09

4. Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study;Journal of Clinical Oncology;2023-01-10

5. Harnessing Antitumor CD4+ T Cells for Cancer Immunotherapy;Cancers;2022-01-05